Recovery of Investment Losses – ElectroCore LLC
The White Law Group is investigating potential securities claims involving broker-dealers who may have unsuitably recommended ElectroCore LLC to investors.
ElectroCore, Inc. (ECOR), a commercial stage medical device company, reportedly engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems., according to MarketWatch.
The company reportedly filed a form D to raise capital from investors in 2017. The total offering amount sold was purportedly $36,000,000, according to SEC filings.